New gout drug shows promise in lowering uric acid levels
NCT ID NCT07280156
First seen Dec 12, 2025 · Last updated May 12, 2026 · Updated 25 times
Summary
This study tests a new medicine called PRX-115, given through a vein, to see if it can safely lower uric acid levels in adults with gout who haven't been helped by standard pills. About 150 people will receive either PRX-115 (with or without methotrexate) or a placebo over 24 weeks. The main goal is to see how many patients can keep their uric acid below a target level for most of the sixth month.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bioclinical Research Alliance, Inc
RECRUITINGMiami, Florida, 33155, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.